# Post Coronary Artery Bypass Graft (CABG) Study

> **NCT00000463** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia

## Interventions

- **DRUG:** lovastatin
- **DRUG:** cholestyramine
- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT00000463
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1987-04
- **Primary completion:** —
- **Final completion:** 1998-12
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000463, "Post Coronary Artery Bypass Graft (CABG) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*